Establishment and characterization of novel highly aggressive HER2‑positive and triple‑negative breast cancer cell lines.
Thongchot S, Jamjuntra P, Prasopsiri J, Thuwajit P, Sawasdee N, Poungvarin N, Warnnissorn M, Sa-Nguanraksa D, O-Charoenrat P, Yenchitsomanus PT, Thuwajit C.
Thongchot S, et al. Among authors: thuwajit p, thuwajit c.
Oncol Rep. 2021 Dec;46(6):254. doi: 10.3892/or.2021.8205. Epub 2021 Oct 15.
Oncol Rep. 2021.
PMID: 34651665
Free PMC article.